HealthEquity, Inc. (HQY) Stock: Price, Forecast & Analyst Target
HealthEquity, Inc. (HQY) — MoonshotScore 90/100 (Exceptional band), calculated Nov 18, 2026. Price $97.31 (-4.45%), as of the Nov 18, 2026 trading session; market cap $8.05B. Expected results Dec 1, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 31.45× (cash as of Jul 31, 2026) · expected results Dec 1, 2026
HealthEquity, Inc. · HQY · NASDAQ · Healthcare · Health Information Services
Research dated 2026-09-13: HealthEquity administers tax-advantaged health accounts and related benefits through a cloud platform, while also earning from payment activity and the economics of HSA cash. Its case depends on whether expanding account economics and operating leverage can keep lifting profit and cash generation while debt remains well above cash.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · HealthEquity (HQY)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality, a strong balance sheet and elite growth, but a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Compounding; Momentum: Surging.
- EPS beat 7 of the last 8 reports
- Altman Z 4.88 · Piotroski F 8
- ROE 11.4% · ROA 7.2% · current ratio 2.99 · earnings yield 2.8% · free-cash-flow yield 5.6%
Helping: business quality, balance-sheet strength, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 91 | Exceptional | |
| 91 | Exceptional | |
| 91 | Exceptional | |
| 91 | Exceptional | |
| 90 | Exceptional | |
| 90 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $97.31 | |
| Change on the day | -4.45% | |
| 52-week range | $72.76–$110.26 | |
| Market capitalisation | $8.05B | — |
| Price / earnings (trailing) | 36.37 | |
| Shares traded on the day | 1.29M | |
| Beta (volatility vs the S&P 500) | 0.19 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For fiscal 2027, we now expect revenue between $1.411 billion and $1.421 billion.
James Lucania · Statement from
Second, as a reminder of the cadence we set last year, we expect to publish year-end sales metrics after the conclusion of our January 31st fiscal year, and we will provide fiscal 2028 guidance when we report our fiscal 2027 year-end financial results.
Richard Putnam · Statement from
How to read these dates
A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for HealthEquity (HQY): perspectives
Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
One of these lenses reads this company less favourably than the MoonshotScore does: Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is HealthEquity (HQY), and what does it report?
Short answer · as of
HealthEquity is not a healthcare provider. It supplies the account infrastructure through which consumers and employers manage health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits, with tools for bill payment, cost comparison and investing.
Research dated 2026-09-13.
Reported revenue blends service fees, credit and debit card activity, and other financial services. Those lines measure administration, platform usage, payment activity and financial economics rather than the volume of medical care delivered.
What do the latest results show for HealthEquity (HQY)?
Research dated 2026-09-13.
Revenue eased from the preceding quarter but remained above the comparable prior period. Operating profit, net income and diluted earnings also stepped down sequentially while staying ahead of their prior-period counterparts.
Across the annual series, revenue advanced throughout the reported span as losses gave way to rising profits, even while research and development spending increased. The recent earnings record also shows repeated revenue and earnings beats against estimates.
Management currently expects further annual revenue expansion and explicitly includes the average yield on HSA cash among its outlook assumptions. That yield is a stated business sensitivity, not a demonstrated explanation for every quarterly movement.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $350.73M Jul 31, 2026
- Latest quarter · R&D
- $73.92M Jul 31, 2026
- Latest quarter · SG&A
- $58.08M Jul 31, 2026
- Latest quarter · FMP standardized operating result
- $98.69M Jul 31, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jul 31, 2026 | $350.73M | $73.92M | $58.08M | $98.69M |
| Apr 30, 2026 | $354.64M | $67.77M | $57.96M | $102.95M |
| Jan 31, 2026 | $334.59M | $70.35M | $171.43M | $67.37M |
| Oct 31, 2025 | $322.16M | $65.92M | $55.29M | $79.85M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $350.70M Aug 27, 2026
- Latest report · revenue estimate
- $349.22M Aug 27, 2026
- Latest report · revenue vs estimate
- Above estimate Aug 27, 2026
- Latest report · EPS vs estimate
- Above estimate Aug 27, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Aug 27, 2026 | $350.70M | $349.22M | $1.2400 | $1.1900 |
| May 28, 2026 | $354.64M | $352.02M | $1.2400 | $1.1100 |
| Mar 17, 2026 | $334.60M | $332.32M | $0.9500 | $0.8900 |
| Dec 3, 2025 | $322.20M | $320.63M | $1.0100 | $0.9120 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Jul 2025 | $326M | $60M | $0.68 (diluted) |
| Q3 FY2026 | $322M | $52M | $0.59 (diluted) |
| Q4 FY2026 | $335M | $50M | $0.58 (diluted) |
| Q1 FY2027 | $355M | $69M | $0.82 (diluted) |
What are the financial strengths and risks for HealthEquity (HQY)?
Short answer
Cash and short-term investments were $256.00M at the Jul 31, 2026 balance-sheet date. Operating cash flow was $136.16M for the quarter ended Jul 31, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Operating cash flow was positive in every reported quarter and strengthened in the latest period, while recent capital expenditure was modest. That cash generation supplies internal capacity for growth initiatives and capital allocation.
Debt substantially exceeds cash and short-term investments, and the cash balance has declined across the reported window despite positive operating cash flow. Supportive liquidity ratios and financial-quality screens reduce immediate strain but do not remove the balance-sheet tradeoffs.
A weaker yield on HSA cash could pressure an earnings mechanism that management explicitly incorporates into its outlook. Growth spending, repurchases, revolver reduction and portfolio acquisitions must also compete for the same financial capacity.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $136.16M Jul 31, 2026
- Previous quarter · operating cash flow
- $97.53M Apr 30, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jul 31, 2026 | $136.16M | −$980,000 |
| Apr 30, 2026 | $97.53M | −$360,000 |
| Jan 31, 2026 | $117.92M | −$16.38M |
| Oct 31, 2025 | $138.57M | −$780,000 |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at HealthEquity (HQY)?
Short answer · as of
The next earnings report is expected on Dec 1, 2026.
Research dated 2026-09-13.
The scheduled earnings report carries a revenue expectation slightly below the latest result. Watch whether revenue stabilizes, operating profit resumes its advance and operating cash flow remains firm; recent estimate beats make the comparison with expectations relevant, but the underlying direction matters more than another beat.
Beyond the headline result, watch the realized yield on HSA cash, the year-end sales metrics when published, and the allocation of cash among repurchases, revolver reduction and portfolio acquisitions. Management has identified each of these as an upcoming operating or capital-allocation consideration.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
We now expect average yield on HSA cash to be between 3.85% and 3.9% during fiscal 2027.
James Lucania ·
Our guidance also reflects funding growth initiatives in the second half of the year, expected capital allocation activity, including additional share repurchase under the expanded authorization, and potential reductions in revolver borrowings during the year. With continued strong cash flow and revolver availability, we expect to maintain ample capacity for portfolio acquisitions should attractive opportunities become available.
James Lucania ·
How does HealthEquity compare with its peers?
Short answer
HealthEquity's score ranks 3rd of 6 in the bounded comparison shown, against 5 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
HealthEquity combines benefits administration with payment and custodial-financial economics. Service revenue sits beside card revenue and other financial services, while the platform spans health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits.
That mix makes account balances, HSA cash yield, member payment activity and administration demand relevant at the same time. A comparison based only on benefits-software fees would therefore miss material parts of how HealthEquity earns revenue.
| Company | Price | Market value | Score |
|---|---|---|---|
| $70.53 Nov 18, 2026 | $9.34B | 94 5-pillar Nov 18, 2026 | |
| $320.00 Nov 19, 2026 | $12.6B | 92 5-pillar Nov 18, 2026 | |
| HealthEquity (HQY) — this page | $97.31 | $8.05B | 90 |
| $68.34 Nov 18, 2026 | $13.6B | 87 5-pillar Nov 18, 2026 | |
| $156.24 Nov 19, 2026 | $9.83B | 76 5-pillar Nov 18, 2026 | |
| $206.56 Nov 18, 2026 | $10.8B | 68 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $108.00 – $142.00
- Consensus target
- $118.14
- Median target
- $115.00
Consensus record · Captured .
Measured against a quoted price of $97.31 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 15, 2026
- Transactions
- 35
- Identified insiders
- 15
- Purchases
- 2
- Sales
- 8
- Other transactions
- 25
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Reporting holders
- 533 Period end Sep 30, 2026
- Previous quarter · holders
- 512 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 11,301,328 |
| Wasatch Advisors LP | 7,011,469 |
| Vanguard Portfolio Management LLC | 3,951,899 |
| Morgan Stanley | 3,806,596 |
| Vanguard Capital Management LLC | 3,575,041 |
Tracked investors
Which of the 16 named investors we follow held HQY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported HQY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about HealthEquity (HQY)?
HQY Healthcare Stock FAQ
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How does Advisor extend HealthEquity’s HSA platform?
Advisor adds automated online guidance and investment choices to account administration, allowing members to manage and grow health savings within the broader platform.
Why does HealthEquity disclose the yield on HSA cash?
Management treats the yield earned on HSA cash as an outlook assumption, showing that account balances contribute financial economics alongside service and card revenue. A lower realized yield would weaken that contribution unless offset elsewhere.
How do COBRA and commuter benefits fit into HealthEquity?
COBRA continuation services and pretax commuter programs broaden HealthEquity beyond health savings accounts. They place additional employer-benefit administration on the same general platform and distribution network.
Can HealthEquity fund buybacks while reducing its revolver?
Positive operating cash flow provides capacity for capital allocation, and management expects repurchases and possible revolver reductions. Debt remains well above cash, however, so buybacks, repayment, growth spending and acquisitions remain competing uses of funds.
What is the HQY stock price today?
The last price recorded for HealthEquity, Inc. (HQY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the HQY price target?
The analyst consensus price target for HealthEquity, Inc. (HQY), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 78 figures on this page — 1 from SEC filings and earnings calls, 69 from Financial Modeling Prep (FMP), 4 with no recorded source, 3 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com